Diseases Archives - Page 2 of 45 - Pharma Journalist

Yeztugo Becomes First FDA-Approved HIV Prevention with 6-Month Protection

Actio Biosciences Raises $66M in Series B to Advance Genetics-Based Therapies

FNP-223 Receives FDA Fast Track Designation for Progressive Supranuclear Palsy

J&J Seeks FDA Approval of STELARA for Pediatric Crohn’s Disease

Sanofi to Acquire Blueprint Medicines, Boosting Rare Disease and Immunology Pipeline

REVEAL GENOMICS and Ona Therapeutics Partner on Next-Gen Cancer Therapy

Apellis Gets FDA Priority Review for EMPAVELI in C3G, IC-MPGN

SK bioscience and Hilleman Laboratories Announce Joint Development of Second-Generation Zaire Ebola Virus Vaccine

Kesin Pharma Announces FDA Approval and U.S. Availability of LIKMEZ (metronidazole) Oral Suspension

Regeneron to Acquire Decibel Therapeutics, Strengthening Gene Therapy and Hearing Loss Programs